PD-L1 ("PROGRAMMED DEATH-LIGAND 1") ANTIBODIES
- 专利权人:
- 发明人:
- 申请号:
- EP16757470.6
- 公开号:
- EP3341020A1
- 申请日:
- 2016.08.18
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要:
- The present invention relates to antibodies that bind human programmed cell death 1 ligand 1 (PD-L1), and may be useful for treating solid and hematological tumors alone and in combination with chemotherapy and other cancer therapeutics.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Multispecific antibodies for use in the treatment of urinary neoplasms
- Antibodies to NTB-A
- ANTIBODIES TO NTB-A
- Vaccines for the treatment of neoplasms from viral capsules of birnavirus containing human papillomavirus antigens
- SUBCUTANEOUS ANTI-HLA-DR MONOCLONAL ANTIBODY FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES